within Pharmacolibrary.Drugs.ATC.L;

model L04AE05
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.52,
    Cl             = 0.1716666666666667,
    adminDuration  = 600,
    adminMass      = 0.002,
    adminCount     = 1,
    Vd             = 0.214,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0035166666666666666,
    Tlag           = 10.020000000000001
  );

  annotation(Documentation(
    info ="<html><body><p>Etrasimod is a selective sphingosine 1-phosphate receptor modulator used for the treatment of moderate to severe ulcerative colitis. It is an orally administered immunomodulatory drug approved for medical use.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult subjects following single and multiple doses of oral etrasimod 2 mg.</p><h4>References</h4><ol><li><p>Lee, CA, et al., &amp; Grundy, JS (2024). Safety, Pharmacokinetics, and Pharmacodynamics of Etrasimod: Single and Multiple Ascending Dose Studies in Healthy Adults. <i>Clinical pharmacology in drug development</i> 13(5) 534–548. DOI:<a href=&quot;https://doi.org/10.1002/cpdd.1379&quot;>10.1002/cpdd.1379</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/38345530/&quot;>https://pubmed.ncbi.nlm.nih.gov/38345530</a></p></li><li><p>Darpo, B, et al., &amp; Grundy, JS (2024). Cardiovascular Evaluation of Etrasimod, a Selective Sphingosine 1-phosphate Receptor Modulator, in Healthy Adults: Results of a Randomized, Thorough QT/QTc Study. <i>Clinical pharmacology in drug development</i> 13(4) 326–340. DOI:<a href=&quot;https://doi.org/10.1002/cpdd.1388&quot;>10.1002/cpdd.1388</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/38441346/&quot;>https://pubmed.ncbi.nlm.nih.gov/38441346</a></p></li><li><p>Bencardino, S, et al., &amp; Danese, S (2023). Efficacy and Safety of S1P1 Receptor Modulator Drugs for Patients with Moderate-to-Severe Ulcerative Colitis. <i>Journal of clinical medicine</i> 12(15) –. DOI:<a href=&quot;https://doi.org/10.3390/jcm12155014&quot;>10.3390/jcm12155014</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/37568417/&quot;>https://pubmed.ncbi.nlm.nih.gov/37568417</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end L04AE05;
